98%
921
2 minutes
20
This study was conducted to compare the anesthetic effects of 2,2,2-tribromoethanol (TBE, Avertin®) in ICR mice obtained from three different sources. TBE (2.5%) was intraperitoneally injected at three doses: high-dose group (500 mg/kg), intermediate-dose group (250 mg/kg), and low-dose group (125 mg/kg). Anesthesia time, recovery time, end-tidal peak CO (ETCO), mean arterial blood pressure, heart rate, oxygen saturation (SpO), body temperature, pH, PCO, and PO of the arterial blood were measured. Stable anesthesia was induced by all doses of TBE and the anesthesia time was maintained exhibited dose dependency. No significant differences in anesthetic duration were found among the three different strains. However, the anesthesia time was longer in female than in male mice, and the duration of anesthesia was significantly longer in female than in male mice in the high-dose group. The recovery time was significantly longer for female than male mice in the intermediate- and high-dose groups. In the ICR strains tested, there were no significant differences in the mean arterial blood pressure, SPO, arterial blood PCO, and PO, which decreased after TBE anesthesia, or in heart rate and ETCO, which increased after TBE anesthesia. In addition, body temperature, blood biochemical markers, and histopathological changes of the liver, kidney, and lung were not significantly changed by TBE anesthesia. These results suggested that ICR mice from different sources exhibited similar overall responses to a single exposure to TBE anesthesia. In conclusion, TBE is a useful drug that can induce similar anesthetic effects in three different strains of ICR mice.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333612 | PMC |
http://dx.doi.org/10.5625/lar.2018.34.4.270 | DOI Listing |
J Am Assoc Lab Anim Sci
May 2025
Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, Massachusetts.
Extended-release buprenorphine formulations are commonly used to control postoperative pain in rodents with minimal handling-related stress. An FDA-indexed formulation is now available that has been demonstrated safe and effective with ketamine-xylazine and isoflurane anesthesia; however, safe use in combination with tribromoethanol, a nonpharmaceutical-grade anesthetic sometimes favored for short, high-volume procedures, has not been reported. Effects on pregnancy and offspring have also not been examined.
View Article and Find Full Text PDFBMC Gastroenterol
April 2025
Division of Gastroenterology and Hepatology, Mayo Clinic, 200 1st St. SW, Rochester, MN, 55905, USA.
Background: Peroral endoscopic myotomy (POEM) is an increasingly utilized endoscopic therapy for achalasia. When undergoing esophagogastroduodenoscopy (EGD), patients with a diagnosis of achalasia may receive endotracheal intubation (EI) to reduce the risk of aspiration. The risk of aspiration on post-POEM EGD should be reduced due to improved esophageal emptying.
View Article and Find Full Text PDFVet Immunol Immunopathol
April 2025
Department of Biomedical Sciences, College of Veterinary Medicine, University of Georgia, 501 DW Brooks Drive, Athens, GA 30602, United States. Electronic address:
Mus musculus, the house mouse, is the most widely used mammalian model in biomedical research. Mice frequently undergo injectable anesthesia for numerous research procedures, with the most common anesthetic protocol being ketamine-xylazine (K/X). 2,2,2-Tribromoethanol (TBE), a non-regulated chemical, is also used, but has been linked to peritonitis.
View Article and Find Full Text PDFMed Educ
August 2022
Division of Medical Toxicology, Department of Emergency Medicine, Brigham and Women's Hospital, Harvard Medical School, Harvard Humanitarian Initiative, Boston, Massachusetts, USA.
Purpose: War negatively impacts health professional education when health care is needed most. The aims of this scoping review are to describe the scope of barriers and targeted interventions to maintaining health professional education during war and summarise the research.
Methods: We conducted a scoping review between 20 June 2018 and 2 August 2018.
Acta Vet Scand
September 2020
Small Animal Clinic, Department for Companion Animals, University of Veterinary Medicine, Vienna, Austria.
Background: Tick-borne encephalitis (TBE) is a zoonotic neurological disease caused by tick-borne encephalitis virus (TBEV), a flavivirus endemic in parts of Europe and Asia. Seroconversion without signs of clinical disease is common in dogs and most of the cases previously described have been tentatively diagnosed by combining neurologic signs with serum antibody titres. Here, the first Scandinavian RT-qPCR-confirmed clinical case of TBE in a dog is reported.
View Article and Find Full Text PDF